Time to Develop and Predictors for Incidence of Tuberculosis among Children Receiving Antiretroviral Therapy

Table 3

Time to developed TB incidence for seropositive children attending HIV/AIDS care in public hospitals between January 2011 and December 31/2020, North West Ethiopia ().

Years	No. of children at started	Withdrawn during year	At risk children	No. of TB case (63)	TB incidence	Cumulative probability	Survival rate	95% CI
>1 year	421 (100)	13 (20.6)	408(96.9%)	13 (20.6)	13 (3.1%)	13 (20.6%)	96.7%	94.5-98.1
2 years	408 (96.9%)	18 (28.5%)	390(92.6%)	18 (28.5%)	18 (4.3%)	31 (49.2%)	90.5%	86.5-93.2
3 years	390 (92.6%)	8 (12.6%)	382(90.7%)	8 (12.6%)	8 (1.99%)	39 (61.8%)	86.3%	81.5-89.9
4 years	382 (90.7%)	5 (7.93%)	377(89.5%)	5 (7.93%)	5 (1.15%)	44 (69.7%)	82.5%	76.5-87.1
5 years	377 (89.5%)	12 (19.0%)	365(86.6%)	12 (19.0%)	12 (2.8%)	56 (88.7%)	61.9%	49.5-72.8
6 years	365 (86.6%)	4 (6.34%)	361(85.7%)	4 (6.34%)	4 (0.98%)	60 (95.1%)	38.9%	29.1-57.5
7 years	361 (85.7%)	2 (3.17%)	359(85.2%)	2 (3.17%)	2 (0.047%)	62 (98.2%)	29.9%	26.5-46.4
End of follow	358 (84.8%)	1 (1.72%)	358(84.8%)	1 (1.72%)	1 (0.023%)	63 (100)	28.5%	22.3-36.9
Total		63 (100)	—	63 (100)	—	100	—	—